Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Leukemia 1Hematologic Diseases 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Surveys and Questionnaires 9Standard of Care 5Endoscopic Mucosal Resection 5Educational Status 5Blood Specimen Collection 5Diet Therapy 3Referral and Consultation 2Quality of Life 2Practice Guidelines as Topic 2Palliative Care 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Control Groups 2Aprepitant 2Acceptance and Commitment Therapy 2vandetanib 1fosaprepitant 1dolasetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Weights and Measures 1Tomography, X-Ray Computed 1Therapeutics 1Surgical Instruments 1Sunitinib 1Sorafenib 1Sampling Studies 1Restraint, Physical 1Remote Patient Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gastrointestinal Neoplasms × Remote Patient Monitoring × Clear all
NCT05038254 2025-08-12

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

M.D. Anderson Cancer Center

Phase NA Active not recruiting
750 enrolled
Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡